Europe Veterinary Healthcare market Segmented by Products Animal diagnostic technologies, Animal genetics, By animal types Trends & Forecasts (2017 - 2022)

Europeveterinary healthcare market was valued at USD 6,560 million in the year 2014 and is expected to grow at a healthy CAGR of 4.98% to USD 8,779 million by the year 2020. The European swine healthcare market is the second largest in the world, amounting to USD 371 million in the year 2014 and is expected to grow at a CAGR of 7.51% to reach USD 573 million by the year 2020. It runs just behind the US in the global fish healthcare market, which happens to be another promising segment in European veterinary healthcare market

EuropeVeterinary Healthcare Market- Market Dynamics

The report details several driving factors and restraints for the veterinary healthcare market in Europe. Some of these are listed below.


Increase in pet ownership

Improved nutrition

Intensifying consumer focus on food safety

Growing awareness about livestock diseases


Increased competition for cultivated land and cost-effective production are the hurdles faced by the European veterinary healthcare market.

The report provides an exhaustive coverage of the market with multi-level segmentation by animal species (farm animals and companion animals), type of healthcare products (vaccines, parasiticides, Anti-invectives, medicinal feed additives, and other pharmaceuticals) and geography. Regional coverage includes a study of the animal healthcare markets in France, Italy Germany, Spain, and Sweden.

Some of the key players in the market are:

Bayer Healthcare

Boehringer Ingelheim

Ceva Animal Health, Inc.



Merial (Animal Health Division of Sanofi)


What the Report Offers

Market definition for Europeveterinary healthcare market along with identification of key drivers and restraints for the market.

Market analysis for Europeveterinary healthcare market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect Europeveterinary healthcare market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.


1.1 Market Definition

1.2 Market Recent Trends

2 Market Analysis

2.1 Market Animal Health Products

2.2 Animal medicines vs. human Medicines

3. Market Dynamics

3.1 Market Drivers

3.1.1 Increase in pet ownership

3.1.2 Improved Nutrition

3.1.3 Intensifying consumer focus on food safety

3.1.4 Greater Livestock production

3.1.5 Increasing Zoonotic and Foodborne Diseases

3.2 Market Constraints

3.2 1 Scarcity of arable land and water

3.2.2 Increased competition for cultivated land

3.2.3 Cost-effective production

3.3 Porter's Five Force Analysis

3.3.1 Threat of New Entrant

3.3.2 Internal Rivalry

3.3.3 Buyer bargaining power

3.3.4 Supplier bargaining power

3.3.5 Threat of substitutes

4. Europe Veterinary healthcare Market Segmentation- Animal Types, based on products

4.1 Companion Animal health

4.1.1 Vaccines

4.1.2 Parasiticides

4.1.3 Anti-Infectives

4.1.4 Medicinal Feed Additives

4.1.5 Other Pharmaceuticals

4.2 Farm Animals

4.2.1 Vaccines

4.2.2 Parasiticides

4.2.3 Anti-Infectives

4.2.4 Medicinal Feed additives

4.2.5 Other Pharmaceuticals

5. Europe Veterinary Diagnostics Market

5.1 Enzyme Linked Immuno Sorbent Assay (ELISA)

5.2 Rapid Immuno Migration (RIM)

5.3 Agar gel Immuno Diffusion (AGID)

6. Europe Veterinary Genetics Market

6.1 HD 50K for Angus

6.2 CLARIFIDE ? for Dairy

6.3 Sheep 50K

6.4 CLARIFIDE ? for Nelore

7. Europe Veterinary Healthcare Market Segmentation- By Animal Species

7.1 Farm animal

7.1.1 Cattle

7.1.2 Swine

7.1.3 Poultry

7.1.4 Fish

7.1.5 Sheep

7.2 Companion Animals

7.2.1 Dogs

7.2.2 Cats

7.2.3 Horses

8. Europe Veterinary healthcare market- Country-level Analysis

8.1 France

8.2 Germany

8.3 Italy

8.4 Spain

8.5 Sweden

9. Competitive landscape

9.1 Major players in the market

9.2 Mergers and acquisitions

9.3 New product launches

9.4 Agreement, Collaborations, and Partnerships

10. Company profiles

10.1 Zoetis animal healthcare

10.1.1 Financial Overview

10.1.2 Business overview

10.1.3 Business strategies

10.2 Merck

10.2.1 Financial Overview

10.2.2 Business overview

10.2.3 Business strategies

10.3 Merial (Animal Health Division of Sanofi)

10.3.1 Financial Overview

10.3.2 Business overview

10.3.3 Business strategies

10.4 Elanco

10.4.1 Financial Overview

10.4.2 Business overview

10.4.3 Business strategies

10.5 Bayer healthcare

10.5.1 Financial Overview

10.5.2 Business overview

10.5.3 Business strategies

10.6 Ceva Animal Health, Inc.

10.6.1 Financial Overview

10.6.2 Business overview

10.6.3 Business strategies

10.7 Virbac

10.7.1 Financial Overview

10.7.2 Business overview

10.7.3 Business strategies

10.8 Boehringer Ingelheim

10.8.1 Financial Overview

10.8.1 Business overview

10.8.1 Business strategies

11. Appendix

11.1. Abbreviations

11.2. Sources

11.3. Bibliography

11.4. Disclaimer

Content are not available

Choose License Type